Primary PreserFlo MicroShunt Versus Trabeculectomy: Effectiveness and Safety in the Real World

Anoushka N Kothari1, Graham A Lee1,2

  • 1Mayne Academy of Surgery, University of Queensland, Brisbane, QLD 4006, Australia.

PubMed

Insights

PreserFlo MicroShunt (PF) and trabeculectomy effectively manage glaucoma by lowering intraocular pressure (IOP). PF offers faster inflammation resolution and less hypotony, while trabeculectomy shows a trend toward greater IOP reduction.

Area of Science:

  • Ophthalmology
  • Surgical Innovation
  • Glaucoma Management

Background:

  • Trabeculectomy is the standard glaucoma surgery but carries risks of serious complications.
  • The PreserFlo MicroShunt (PF) offers a less invasive surgical option for glaucoma management.
  • Comparing the safety and efficacy of PF against trabeculectomy is crucial for surgical decision-making.

Purpose of the Study:

  • To compare the effectiveness and safety of the PreserFlo MicroShunt (PF) versus trabeculectomy for glaucoma treatment.
  • To evaluate intraocular pressure (IOP) reduction, medication usage, and complication rates between the two surgical methods.
  • To assess visual acuity and post-operative recovery metrics in patients undergoing PF or trabeculectomy.

Main Methods:

  • Retrospective cohort analysis of 95 eyes (48 PF, 47 trabeculectomy) from a single Australian private practice.
  • Data collected from November 2017 to January 2024, utilizing Inverse Probability of Treatment Weighting (IPTW) for covariate adjustment.
  • Weighted regression and Cox proportional hazards models were employed to estimate treatment effects on primary and secondary outcomes.

Main Results:

  • Both PF and trabeculectomy significantly reduced IOP and medication needs at 12 months, with no statistically significant difference between groups.
  • Qualified success rates were comparable (74.9% PF vs. 72.5% trabeculectomy).
  • PF demonstrated a lower incidence of early hypotony (when stented) and faster post-operative inflammation resolution (HR: 6.3, p < 0.001), while trabeculectomy showed a non-significant trend towards lower IOP and fewer revisions.

Conclusions:

  • Both PreserFlo MicroShunt and trabeculectomy are effective glaucoma surgical options.
  • PF is a less invasive procedure associated with reduced early hypotony and quicker inflammation recovery.
  • Further long-term studies and enhanced anti-fibrotic strategies are needed to optimize glaucoma surgical outcomes.